A detailed history of Genus Capital Management Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Genus Capital Management Inc. holds 1,550 shares of JNJ stock, worth $240,978. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,550
Previous 1,550 -0.0%
Holding current value
$240,978
Previous $227 Million 10.88%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$155.22 - $162.74 $284,052 - $297,814
1,830 New
1,830 $289 Million
Q3 2023

Oct 31, 2023

BUY
$155.75 - $174.48 $862,543 - $966,270
5,538 Added 247.01%
7,780 $1.21 Billion
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $346,052 - $372,418
2,242 New
2,242 $371 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Genus Capital Management Inc. Portfolio

Follow Genus Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genus Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Genus Capital Management Inc. with notifications on news.